U.S. Preventive Services Task Force recommended all women get screened for breast cancer every other year aged 40 to 74
On Apr. 30, 2024, the U.S. Preventive Services Task Force (USPSTF) recommended that all women get screened for…
Biotechnology | Diagnostics | Disease | Genomics | NIH | Oncology | Therapeutics
Analysis identified 50 new genomic regions associated with kidney cancer risk
On Apr. 26, 2024, an international team of researchers led by the National Cancer Institute (NCI) released an…
Microsoft and Fred Hutch Working together to end cancer faster
On Mar. 14, 2024, Microsoft and the Fred Hutch announced a collaboration to end cancer faster, applying machine…
Clinical study of a blood test shows 83% accuracy for detecting colorectal cancer
On Mar. 13, 2024, the Fred Hutchinson Cancer Center announced that a blood test intended for screening for…
Fred Hutch to lead new federal Cancer Screening Research Network
On Feb. 21, 2024, the Fred Hutchinson Cancer Center announced it was at the helm of a new…
CPRIT approved almost $100 million in grants to advance the fight against cancer in Texas
On Feb. 21, 2024, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had approved $98,592,155…
Health effects associated with exposure to secondhand smoke: a Burden of Proof study
On Jan. 9, 2024, the Institute for Health Metrics and Evaluation (HHMI) reported that despite a gradual decline…
Molecular jackhammers’ ‘good vibrations’ eradicate cancer cells
On Dec. 19, 2023, a research team led by Rice University reported they found that the atoms of…
Pfizer completed acquisition of Seagen for $43 billion
On Dec. 14, 2023, Pfizer announced it had completed the acquisition of Seagen, a global biotechnology company based…
Biotechnology | Diagnostics | Disease | Oncology | Vaccine | Women's Health
Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
On Dec. 6, 2023, Anixa Biosciences announced updated positive results from the Phase 1 clinical trial of its…
Biotechnology | Diagnostics | Disease | Genomics | Neurology | Oncology | Therapeutics
World’s largest genetic project unveiled incredible new data
On Nov. 30, 2023, in a momentous landmark for medical research, UK Biobank announced that it had unveiled…
CPRIT invested $63 million to bring innovative researchers and companies to Texas
On Nov. 15, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
The White House lanuched Initiative on Women’s Health Research
On Nov. 13, 2023, the White House announced the first-ever Initiative on Womenﾒs Health Research, an effort led…
Purdue nameed new pediatric cancer research center for the late Tyler Trent
On Oct. 14, 2023, Purdue University ensured that the memory of the former graduate and devoted Boilermaker football…
Biotechnology | Chemical | Disease | Oncology
California became first U.S. state to ban red dye No. 3
On Oct. 7, 2023, California became the first state to ban four chemicals used in well-known candies and…
New cancer diagnoses fell abruptly early in the COVID-19 pandemic according to Annual Report to the Nation
On Sept. 27, 2023, the U.S. Centers for Disease Control and Prevention (CDC) reported that new diagnoses of…
Diagnostics | Disease | Medical Device | NIH | Oncology | Therapeutics | U.S. Congress
ARPA-H launched program for real-time drug delivery and disease tracking to improve patient self-care
On Sept. 26, 2023, the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department…
Biotechnology | Diagnostics | Disease | NIH | Oncology | Radiology | Therapeutics | Women's Health
High levels of particulate air pollution associated with increased breast cancer incidence
On Sept. 11, 2023, researchers at the National Institutes of Health (NIH) reported that living in an area…
The Markey Cancer Center became an NCI-designated Comprehensive Cancer Center
On Sept. 6, 2023, the Markey Cancer Center (MCC) became Kentucky’s first and only National Cancer Institute (NCI)-Designated…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics | Women's Health
FDA Cleared 23andMe improved BRCA report for communities underrepresented in genetic testing
On Aug. 31, 2023, the U.S. Food and Drug Administration (FDA) cleared for marketing the updated 23andMe Personal…
CPRIT awarded more than $49 million to Texas institutions for cancer research and prevention
On Aug. 16, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had approved over…
U.S. Preventive Services Task Force recommended that all women get screened for breast cancer every other year starting at age 40
On May 9, 2023, the U.S. Preventive Services Task Force (USPSTF) recommended that all women get screened for…
Oregon Health Sciences University dermatologists detected the world’s smallest skin cancer
On May 1, 2023, an Oregon Health Sciences University (OHSU) dermatologist and a multi-disciplinary team confirmed that a…
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics
U.S. Preventive Services Task Force issued recommendation on screening for skin cancer
On Apr. 18, 2023, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening…
Hutchinson Cancer Center announced new “patient-centric” building in South Lake Union
On Mar. 23, 2023, the Fred Hutchinson Cancer Center (FHCRC) announced a new building in South Lake Union…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics | Women's Health
FDA updated mammography regulations to require reporting of breast density information and facility oversight
On Mar. 9, 2023, the U.S. Food and Drug Administration (FDA) announced that it had published updates to…
CPRIT approved $12 million to bring top-flight cancer researchers to Lone Star State
On Feb. 15, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced a major step forward…
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics | WHO | Women's Health
WHO launched new roadmap on breast cancer
On Feb. 3, 2023, the World Health Organization (WHO) released an updated Global Breast Cancer Initiative (GBCI) Framework…
Purdue Center for Cancer Research renamed Purdue Institute for Cancer Research
On Jan. 6, 2023, the Purdue Center for Cancer Research announced it was changing its name to the…
Biotechnology | FDA | Oncology | Therapeutics
The FDA approves Genentech’s updated drug labeling for Xeloda (capecitabine) under Project Renewal Pilot Program
On Dec. 24, 2022, the U.S. Food and Drug Administration (FDA) approved updated labeling for Genentech’s capecitabine tablets…